Your browser doesn't support javascript.
loading
Phase I dose escalating study of oral cyclophosphamide in tumour-bearing cats.
Chan, C M; Rassnick, K M; Frimberger, A E; Nguyen, S M; Moore, A S.
Affiliation
  • Chan CM; The Pet Oncologist, 1A Norman Street, Fig Tree Pocket, QLD 4069, Australia. Electronic address: info@thepetoncologist.com.
  • Rassnick KM; Veterinary Medical Center of Central New York, 5841 Bridge Street, East Syracuse, NY 13057, USA.
  • Frimberger AE; Veterinary Oncology Consultants, 379 Lake Innes Drive, Wauchope, NSW 2446, Australia.
  • Nguyen SM; Small Animal Specialist Hospital, 1 Richardson Pl, North Ryde, NSW 2113, Australia.
  • Moore AS; Veterinary Oncology Consultants, 379 Lake Innes Drive, Wauchope, NSW 2446, Australia.
Vet J ; 258: 105450, 2020 Apr.
Article in En | MEDLINE | ID: mdl-32564869
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cat Diseases / Antineoplastic Agents, Alkylating / Maximum Tolerated Dose / Cyclophosphamide / Neoplasms Type of study: Observational_studies Limits: Animals Language: En Journal: Vet J Journal subject: MEDICINA VETERINARIA Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cat Diseases / Antineoplastic Agents, Alkylating / Maximum Tolerated Dose / Cyclophosphamide / Neoplasms Type of study: Observational_studies Limits: Animals Language: En Journal: Vet J Journal subject: MEDICINA VETERINARIA Year: 2020 Document type: Article Country of publication: